103 results
Page 3 of 6
8-K
EX-99.1
9vln7
18 Apr 22
Diffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance Plan
4:25pm
DEFA14A
EX-99.1
1pe0deky72bygn9r
8 Apr 22
Additional proxy soliciting materials
5:05pm
DEFA14A
2of5cbsfiq
8 Apr 22
Additional proxy soliciting materials
5:05pm
8-K
3z1l6kb uhcyn7
8 Apr 22
Diffusion Pharmaceuticals Announces New Date for Previously Announced Special Meeting of Stockholders
5:04pm
8-K
EX-99.1
myoofxf3wf ov5t
8 Apr 22
Diffusion Pharmaceuticals Announces New Date for Previously Announced Special Meeting of Stockholders
5:04pm
DEFA14A
fg0ucs4v0r5
30 Mar 22
Additional proxy soliciting materials
4:33pm
8-K
u0q82ktb2uaxoxvde8
18 Mar 22
Entry into a Material Definitive Agreement
5:14pm
424B5
c2f52yqc6yys 69
17 Feb 21
Prospectus supplement for primary offering
12:00am
424B5
g0n8p5rmd700otjy
11 Feb 21
Prospectus supplement for primary offering
5:28pm
424B2
vhyy5ties4pyzw6qxw
2 Oct 20
Prospectus for primary offering
4:16pm
424B3
d9ikmo4kwo gwy
8 Jun 20
Prospectus supplement
4:48pm